Showing 601-620 of 640 for: Cochrane Systematic Reviews > Cardiovascular 
- Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb
Cochrane Systematic Reviews, 19-Jan-2021
Standard treatment for deep vein thrombosis (DVT) aims to reduce immediate complications. Use of thrombolytic clot removal strategies (i.e. thrombolysis (clot dissolving drugs), with or without additional endovascular techniques), could reduce the long-te
- Thrombolytic therapy for pulmonary embolism
Cochrane Systematic Reviews, 15-Apr-2021
Thrombolytic therapy is usually reserved for people with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE.
- Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery
Cochrane Systematic Reviews, 13-Feb-2008
Paediatric studies have demonstrated that cardiopulmonary bypass is associated with a decline in thyroid hormone levels. Adult patients who undergo open heart surgery and receive triiodothyronine supplementation have demonstrated a dose-dependent increase
- Tianma Gouteng Yin Formula for treating primary hypertension
Cochrane Systematic Reviews, 14-May-2012
Tianma Gouteng Yin Formula (TGYF) is widely used to treat hypertension-related symptoms in clinical practice in East Asia. It has been shown to have a blood pressure lowering effect, reducing total cholesterol, improving clinical symptoms and quality of l
- Ticlopidine versus oral anticoagulation for coronary stenting
Cochrane Systematic Reviews, 23-Oct-2001
A two to four week course of ticlopidine plus aspirin following coronary stenting is considered effective in preventing thrombotic occlusion of the stented vessel and safe in regards to bleeding and peripheral vascular complications. However, rare, althou
- Timing and volume of fluid administration for patients with bleeding
Cochrane Systematic Reviews, 5-Mar-2014
Treatment of haemorrhagic shock involves maintaining blood pressure and tissue perfusion until bleeding is controlled. Different resuscitation strategies have been used to maintain the blood pressure in trauma patients until bleeding is controlled. Howeve
- Timing of surgery for aneurysmal subarachnoid haemorrhage
Cochrane Systematic Reviews, 23-Apr-2001
The timing of surgery to secure a ruptured aneurysm after a subarachnoid haemorrhage is an important issue. Early clipping of an aneurysm prevents rebleeding, a major cause of death after a subarachnoid haemorrhage. However, concerns about the possible de
- Tirilazad for aneurysmal subarachnoid haemorrhage
Cochrane Systematic Reviews, 17-Feb-2010
Delayed cerebral ischaemia is a significant contributor to poor outcome (death or disability) in patients with aneurysmal subarachnoid haemorrhage (SAH). Tirilazad is considered to have neuroprotective properties in animal models of acute cerebral ischaem
- Tongxinluo (Tong xin luo or Tong‐xin‐luo) capsule for unstable angina pectoris
Cochrane Systematic Reviews, 18-Oct-2006
Tongxinluo capsule is a medicine consisting of traditional Chinese herbs and insects used for cardiovascular diseases in China and some other Asian countries. To date the evidence of its effect has not previously been subject to systematic review, making
- Topical agents or dressings for pain in venous leg ulcers
Cochrane Systematic Reviews, 14-Nov-2012
Venous leg ulcers affect up to 1% of people at some time in their lives and are often painful. The main treatments are compression bandages and dressings. Topical treatments to reduce pain during and between dressing changes are sometimes used.
- Topical negative pressure for treating chronic wounds
Cochrane Systematic Reviews, 9-Jun-2015
Chronic wounds mainly affect the elderly and those with multiple health problems. Despite the use of modern dressings, some of these wounds take a long time to heal, fail to heal, or recur, causing significant pain and discomfort to the person and cost to
- Traditional Chinese herbal products for stable angina
Cochrane Systematic Reviews, 12-May-2010
Stable angina pectoris is a common condition, worldwide. Traditional Chinese herbal products (TCHP) are developed for treating stable angina pectoris in China.
- Tranexamic acid for reducing mortality in emergency and urgent surgery
Cochrane Systematic Reviews, 12-Feb-2013
Emergency or urgent surgery, which can be defined as surgery which must be done promptly to save life, limb or functional capacity, is associated with a high risk of bleeding and death. Antifibrinolytic agents, such as tranexamic acid, inhibit blood clot
- Treadmill training and body weight support for walking after stroke
Cochrane Systematic Reviews, 17-Aug-2017
Treadmill training, with or without body weight support using a harness, is used in rehabilitation and might help to improve walking after stroke. This is an update of the Cochrane review first published in 2003 and updated in 2005 and 2014.
- Treatment for femoral pseudoaneurysms
Cochrane Systematic Reviews, 28-Nov-2013
Femoral pseudoaneurysms may complicate up to 8% of vascular interventional procedures. Small pseudoaneurysms can spontaneously clot, but sometimes definitive treatment is needed. Surgery has traditionally been considered the 'gold standard' treatment, alt
- Treatment for superficial thrombophlebitis of the leg
Cochrane Systematic Reviews, 25-Feb-2018
The optimal treatment of superficial thrombophlebitis (ST) of the legs remains poorly defined. While improving or relieving the local painful symptoms, treatment should aim at preventing venous thromboembolism (VTE), which might complicate the natural his
- Treatment for thoracic outlet syndrome
Cochrane Systematic Reviews, 21-Nov-2014
Thoracic outlet syndrome (TOS) is one of the most controversial diagnoses in clinical medicine. Despite many reports of operative and non-operative interventions, rigorous scientific investigation of this syndrome leading to evidence-based management is l
- Treatment of hypertension in peripheral arterial disease
Cochrane Systematic Reviews, 4-Dec-2013
Peripheral arterial disease (PAD) causes considerable morbidity and mortality. Hypertension is a risk factor for PAD. Treatment for hypertension must be compatible with the symptoms of PAD. Controversy regarding the effects of beta-adrenoreceptor blockade
- Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome
Cochrane Systematic Reviews, 3-Apr-2011
Valvular heart disease constitutes the majority of all causes of heart disease in pregnancy. In the presence of valvular heart disease, the necessary haemodynamic changes of pregnancy might cause heart failure, leading to severe maternal and fetal morbidi
- Triflusal for preventing serious vascular events in people at high risk
Cochrane Systematic Reviews, 20-Jul-2005
Aspirin is the standard treatment for secondary prevention of stroke and other vascular events. Several studies suggest that triflusal may have a better safety profile.
